Beck Mack & Oliver’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$169K Hold
10,667
﹤0.01% 191
2026
Q1
$144K Hold
10,667
﹤0.01% 188
2025
Q4
$133K Hold
10,667
﹤0.01% 187
2025
Q3
$106K Hold
10,667
﹤0.01% 180
2025
Q2
$95.3K Hold
10,667
﹤0.01% 181
2025
Q1
$92.9K Hold
10,667
﹤0.01% 179
2024
Q4
$133K Hold
10,667
﹤0.01% 177
2024
Q3
$124K Hold
10,667
﹤0.01% 169
2024
Q2
$113K Hold
10,667
﹤0.01% 169
2024
Q1
$127K Hold
10,667
﹤0.01% 170
2023
Q4
$116K Sell
10,667
-3
-0% -$29 ﹤0.01% 177
2023
Q3
$105K Sell
10,670
-29
-0.3% -$302 ﹤0.01% 163
2023
Q2
$107K Hold
10,699
﹤0.01% 167
2023
Q1
$103K Hold
10,699
﹤0.01% 164
2022
Q4
$119K Hold
10,699
﹤0.01% 166
2022
Q3
$91K Hold
10,699
﹤0.01% 163
2022
Q2
$112K Hold
10,699
﹤0.01% 168
2022
Q1
$116K Hold
10,699
﹤0.01% 184
2021
Q4
$145K Sell
10,699
-868
-8% -$11.6K ﹤0.01% 198
2021
Q3
$157K Sell
11,567
-9
-0.1% -$128 ﹤0.01% 207
2021
Q2
$165K Buy
11,576
+9
+0.1% +$130 ﹤0.01% 196
2021
Q1
$162K Hold
11,567
0.01% 181
2020
Q4
$217K Buy
+11,567
New +$189K 0.01% 180

Other funds holding VTRS

Beck Mack & Oliver's VTRS Position: Q2 2026 in Review

Beck Mack & Oliver held its Viatris (VTRS) position steady in Q2 2026 at 10,667 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #191.

Beck Mack & Oliver first reported a position in VTRS in Q4 2020 and has held it in 23 quarters since. The position peaked at $217K in Q4 2020. 1,024 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Beck Mack & Oliver held 10,667 shares of Viatris worth $169K as of Q2 2026.
  • Beck Mack & Oliver left its Viatris share count unchanged in Q2 2026.
  • Viatris made up ﹤0.01% of Beck Mack & Oliver's portfolio in Q2 2026, its #191 holding.
  • Beck Mack & Oliver first reported a position in Viatris in Q4 2020 and has held it in 23 quarters since.
  • Beck Mack & Oliver's Viatris position peaked at $217K in Q4 2020.
  • 1,024 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Beck Mack & Oliver's 13F filing for Q2 2026, filed 14 Aug 2026.